|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/20 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3351261 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18160057.8 |
| Date of filing the European patent application | 2012-10-10 | |
| (97) | Date of publication of the European application | 2018-07-25 |
| (45) | Date of publication and mention of the grant of the patent | 2021-06-02 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 11184644 | 2011-10-11 | EP | |
| 11188625 | 2011-11-10 | EP | |
| 12185108 | 2012-09-19 | EP |
| (72) |
BECHER, Burkhard , CH
VOM BERG, Johannes , CH
|
| (73) |
Universität Zürich ,
Rämistrasse 71, 8006 Zürich,
CH
|
| (54) | COMBINATION MEDICAMENT COMPRISING IL-12 AND AN AGENT FOR BLOCKADE OF T-CELL INHIBITORY MOLECULES FOR TUMOUR THERAPY |
| COMBINATION MEDICAMENT COMPRISING IL-12 AND AN AGENT FOR BLOCKADE OF T-CELL INHIBITORY MOLECULES FOR TUMOUR THERAPY |